Skip to main content
All lobbying clients

PIERRE FABRE PHARMACEUTICALS, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceuticals

$220,000 Reported spend
10 Filings counted
2 Outside firms hired
0 Bills named

Spend is reported income plus in-house expenses across 10 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as PIERRE FABRE PHARMACEUTICALS INC.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $160,000 7 filings
  • 2025 $60,000 3 filings
 Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 4
  • HOUSE OF REPRESENTATIVES 5
  • SENATE 4
  • Food & Drug Administration (FDA) 1
  • Health & Human Services, Dept of (HHS) 1
 Recent filings 11 total
Q3 report
FARRAGUT PARTNERS LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2026
View → Q3 amendmentNo activity
BROWNSTEIN HYATT FARBER SCHRECK, LLP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 16, 2026
View → Q3 reportNo activity
BROWNSTEIN HYATT FARBER SCHRECK, LLP Amended
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 16, 2026
View → Q2 report
FARRAGUT PARTNERS LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 20, 2026
View → Q2 reportNo activity
BROWNSTEIN HYATT FARBER SCHRECK, LLP
2nd Quarter 2026 (Apr 1 - June 30) · posted Jul 16, 2026
View → Q1 report
FARRAGUT PARTNERS LLP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 20, 2026
View → Q1 report
BROWNSTEIN HYATT FARBER SCHRECK, LLP
1st Quarter 2026 (Jan 1 - Mar 31) · House · $20,000 income · posted Apr 15, 2026
View → Registration
FARRAGUT PARTNERS LLP
1st Quarter 2026 (Jan 1 - Mar 31) · posted Feb 24, 2026
View → Q4 report
BROWNSTEIN HYATT FARBER SCHRECK, LLP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 16, 2026
View → Q3 report
BROWNSTEIN HYATT FARBER SCHRECK, LLP
3rd Quarter 2025 (July 1 - Sep 30) · $10,000 income · posted Oct 17, 2025
View → Registration
BROWNSTEIN HYATT FARBER SCHRECK, LLP
3rd Quarter 2025 (July 1 - Sep 30) · posted Oct 6, 2025
View →
 Foreign entities disclosed 2
  • PIERRE FABRE FOUNDATION France named on 1 filing · highest disclosed ownership 85% · largest disclosed contribution $0
  • PIERRE FABRE SA France named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem